Gamble DT; School of Medicine and Dentistry, University of Aberdeen, United Kingdom.
Ross J; Khan H; Cheyne L; Rudd A; Srivanasan J; Horgan G; Hogg
D; Myint PK; Newby DE; Williams C; Gray SR; Dawson D

Circulation: Heart Failure. 19(3):e013229, 2026 Mar.

BACKGROUND: Takotsubo cardiomyopathy is an acute cardiac emergency
presenting with severe left ventricular dysfunction. Physical exercise
training or cognitive behavioral therapy may enhance myocardial recovery
after takotsubo cardiomyopathy.

METHODS: In a prospective multicenter clinical trial conducted between
February 2020 and August 2023, patients with acute takotsubo
cardiomyopathy were randomized 1:1:1 to physical exercise training,
cognitive behavioral therapy, or standard care for 12 weeks after index
presentation. The primary end point was resting phosphocreatine/gamma-ATP
ratio assessed by 31P-magnetic resonance spectroscopy. Secondary end
points were the rate of oxygen consumption at peak exercise on
cardiopulmonary exercise testing, 6-minute walk distance, left ventricular
global longitudinal strain, and the Minnesota Living With Heart Failure
Questionnaire. Twelve-week changes in outcome were compared between
allocated trial interventions.

RESULTS: Seventy-six participants were recruited: the median age was 66
years, and 91% were women. Compared with standard care, the primary end
point of myocardial phosphocreatine/gamma-ATP ratio was improved by
physical exercise training (0.4 [95% CI, 0.1-0.8]; P=0.016) and cognitive
behavioral therapy (0.3 [0.01-0.7]; P=0.043). Both physical exercise
training and cognitive behavioral therapy improved rate of oxygen
consumption at peak exercise (4.7 [1.4-8.0] and 4.0 [1.5-6.4] mL/min per
kg; P=0.001 and 0.004, respectively) and 6-minute walk distance (92.6
[24.7-160.6] and 73.3 [7.9-138.8] m; P=0.004 and 0.029, respectively)
compared with standard care. There were no differences in global
longitudinal strain or symptom burden.

CONCLUSIONS: In patients with acute takotsubo cardiomyopathy, a 12-week
intervention with exercise training or cognitive behavioral therapy
improved left ventricular myocardial energetics and exercise performance
without demonstrable effects on symptoms of heart failure

Kritikou S; Aristotle University of Thessaloniki, Thessaloniki, GREECE.
Zafeiridis A; Markopoulou A; Boutou A; Zacharias A; Rampiadou
C; Kounti G; Gkalgkouranas I; Kastritseas L; Chloros D; Stanopoulos I;
Pitsiou G; Dipla K

Medicine & Science in Sports & Exercise. 58(4):650-660, 2026 Apr 01.

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive lung
disease characterized by exertional dyspnea, desaturation, and exercise
intolerance. Desaturation may contribute to cerebral hypoxia during
exercise, and in turn, to exercise intolerance. Although pulmonary
rehabilitation (PR) has been shown to improve functional capacity and
symptom management, it remains unclear whether these benefits are
partially mediated by improved brain oxygenation.

PURPOSE: To evaluate whether a 12-month PR program enhances cerebral
oxygenation during exercise in patients with IPF. Secondary outcomes
included exercise capacity, cognitive function, depression/anxiety, and
physical activity levels.

METHODS: Sixteen patients with IPF (68.7 +/- 6.4 yr), on antifibrotic
therapy, completed a 12-mo supervised PR intervention involving aerobic,
resistance, flexibility, and breathing exercises. Pre- and
post-intervention assessments included spirometry, cardiopulmonary
exercise testing, cerebral oxygenation via near-infrared-spectroscopy,
Mini-Mental State Examination, Hospital Anxiety/Depression Scale, and
International Physical Activity Questionnaire.

RESULTS: After the PR intervention, cerebral oxygenated hemoglobin (O 2
Hb mean-response ) during exercise was higher ( P = 0.04) compared with
pre-PR exercise testing. Isowork O 2 Hb responses (at 50% and 75% of
pre-PR peak workload) were significantly elevated ( P = 0.006). The PR
intervention resulted in improved VO 2 peak ( P = 0.01), cardiopulmonary
exercise testing duration, and peak workload ( P = 0.02). Hospital
Anxiety/Depression Scale anxiety/depression scores decreased ( P = 0.01; P
< 0.001); the Mini-Mental State Examination was not significantly changed
( P = 0.054). Physical activity levels increased from “low” to “moderate”
( P < 0.001). Training-induced cerebral oxygenation improvements were
significantly correlated with improvements in exercise capacity (VO 2 peak
% predicted , r = 0.54, P = 0.03; Workload peakr = 0.54, P = 0.03) and
mMRC. ( r = 0.63, P = 0.01).

CONCLUSIONS: A 12-month PR program enhanced cerebral oxygenation during
exercise, improved exercise capacity, physical activity levels, and
psychological well-being of IPF patients. Importantly, our findings
suggest a potential association between improved cerebral oxygenation and
enhanced exercise capacity in IPF.

Lee Y; Department of Radiological Sciences Medical & Imaging Informatics (MII) Group Los Angeles CA
Feng J; Rahrooh A; Bui AAT; Cooper CB; Hsu JJ

Journal of the American Heart Association. 15(6):e045734, 2026 Mar 17.

BACKGROUND: Cardiorespiratory fitness, as measured by peak oxygen uptake
during cardiopulmonary exercise testing, is a prognostic indicator. We aim
to predict peak oxygen uptake from submaximal variables on cardiopulmonary
exercise testing to assess cardiorespiratory fitness when maximal exertion
is not possible.

METHODS: Data from 13535 cardiopulmonary exercise testings were
collected, and patients were divided into a normal group (NG; n=1076) and
other group (OG; n=9823). Regression models to predict maximum oxygen
consumption were trained and evaluated on the NG, OG, and combined groups
(NG+OG) using stratified 5-fold cross-validation. We trained different
models using demographic, resting and submaximal variables.

RESULTS: Optimal models were Bayesian Ridge for the NG and Light Gradient
Boosting Machine for the other groups. The mean (SD) R2 when using
demographic and rest variables was 0.690 (0.027) for the NG, 0.546 (0.012)
for the OG, and 0.562 (0.015) for the NG+OG. When using demographic, rest
and submaximal variables, performance increased to 0.796 (0.020) for the
NG, 0.732 (0.009) for the OG, and 0.761 (0.008) for the NG+OG. Oxygen
consumption at the first ventilatory threshold, minute ventilation at the
second ventilatory threshold, and forced expiratory volume in 1 second
were important features across the models trained with rest and submaximal
variables. Minute ventilation at the second ventilatory threshold had
negative effects, while oxygen consumption at the first ventilatory
threshold and forced expiratory volume in 1 second had positive effects on
maximum oxygen consumption prediction. In exploratory analyses, the
inclusion of chronotropic index improved model performance.

CONCLUSIONS: Our peak oxygen uptake prediction model demonstrated strong
performance using submaximal exercise variables. This methodology offers a
means to assess prognostic markers for individuals who might not achieve
maximal exhaustion during cardiopulmonary exercise testing.

Button B;  Monash University, Melbourne, Australia,
Dharmakumara M; Wilson L; Parry N; Hartley F; Borg B; T Keating D

Canadian Respiratory Journal. 2026(1):e9062245, 2026.

BACKGROUND: The Alfred Step Test Exercise Protocol (A-STEP) and
feasibility study were previously published. The aim here was to determine
the validity of the A-STEP compared to cycle ergometry (CPET) in adults
with CF.

METHODS: The A-STEP and CPET were carried out in random order 2 weeks
apart. A wearable, portable metabolic system was used to measure
breath-by-breath and minute-by-minute sampling of O2, CO2, heart rate, and
VO2. The main outcome measures were VO2max and HRmax.

RESULTS: Seven stable-state adults (3 male) on CFTR modulator therapy
with a mean (SD) and range of age 38.2 (13.4) 26-64 years; height 169.9
(10.9) 149.7-185.3 cm; BMI 22.8 (2.10) 19.5-28 kg/m2; FEV1 79.4 (18.9)
38.0-106.0; and FVC 95.1 (16.7) 63.0-114.0 percent predicted (pp)
completed both A-STEP and CPET. The VO2Max had high correlation and good
agreement between the A-STEP 31.3 (5.9) and CPET 29.8 (6.2) mL/min/kg, r =
0.88. The HRMAX was strongly correlated with the A-STEP 174 (17) bpm and
95.7 (7.4) pp versus 168 (15) bpm and 92.4 (5.3) pp with r = 0.92 and
0.86, respectively. The SpO2Nadir for A-STEP was 91.0 (4.0) and CPET 92.0
(3.3), r = 0.82. The VO2 at the anaerobic threshold (VO2@AT) occurred
significantly earlier for the CPET at 1021 (260) versus A-STEP 1361 (234)
mL/minute, p < 0.05. The VEMax for CPET was 84.1 (18.8) and A-STEP 73.5
(15.8) L/minute, p < 0.05. The AWESCORE also ensured baseline stability.
The number of levels completed during the A-STEP was 10.7 (12.9) ranging
from 9 to 15.

CONCLUSION: The A-STEP may be a portable, valid surrogate to
cardiopulmonary exercise testing using cycle ergometry.

Sietsema, Kathy E; David Geffen School of Medicine at UCLA, Torrance, California.
Rossiter, Harry B.

Seminars in Respiratory & Critical Care Medicine. 44(5):661-680, 2023 Oct.

Aerobic, or endurance, exercise is an energy requiring process supported
primarily by energy from oxidative adenosine triphosphate synthesis. The
consumption of oxygen and production of carbon dioxide in muscle cells are
dynamically linked to oxygen uptake (VO2) and carbon dioxide output (VCO2)
at the lung by integrated functions of cardiovascular, pulmonary,
hematologic, and neurohumoral systems. Maximum oxygen uptake (VO2max) is
the standard expression of aerobic capacity and a predictor of outcomes in
diverse populations. While commonly limited in young fit individuals by
the capacity to deliver oxygen to exercising muscle, (VO2max) may become
limited by impairment within any of the multiple systems supporting
cellular or atmospheric gas exchange. In the range of available power
outputs, endurance exercise can be partitioned into different intensity
domains representing distinct metabolic profiles and tolerances for
sustained activity. Estimates of both VO2max and the lactate threshold,
which marks the upper limit of moderate-intensity exercise, can be
determined from measures of gas exchange from respired breath during
whole-body exercise. Cardiopulmonary exercise testing (CPET) includes
measurement of VO2 and VCO2 along with heart rate and other variables
reflecting cardiac and pulmonary responses to exercise. Clinical CPET is
conducted for persons with known medical conditions to quantify
impairment, contribute to prognostic assessments, and help discriminate
among proximal causes of symptoms or limitations for an individual. CPET
is also conducted in persons without known disease as part of the
diagnostic evaluation of unexplained symptoms. Although CPET quantifies a
limited sample of the complex functions and interactions underlying
exercise performance, both its specific and global findings are uniquely
valuable. Some specific findings can aid in individualized diagnosis and
treatment decisions. At the same time, CPET provides a holistic summary of
an individual’s exercise function, including effects not only of the
primary diagnosis, but also of secondary and coexisting conditions.

Goulart CDL; Federal University of Sao Carlos, UFSCar, Sao Carlos, SP, Brazil.
& several oher institutions
Silva RN; Agostoni P; Franssen FME; Myers J; Arena R;
Borghi-Silva A

Respiratory Medicine. 217:107332, 2023 Oct.

BACKGROUND: Exercise oscillatory ventilation (EOV) is considered an
important variable for predicting poor prognosis in patients with heart
failure (HF) with reduced left ventricular ejection fraction (HFrEF).
However, there are no studies evaluating EOV presence in the coexistence
chronic obstructive pulmonary disease (COPD) and HFrEF.

AIMS: I) To compare the clinical characteristics of participants with
coexisting HFrEF-COPD with and without EOV during cardiopulmonary exercise
testing (CPET); and II) to identify the impact of EOV on mortality during
follow-up for 35 months.

METHODS: 50 stable HFrEF-COPD (EF<50%) participants underwent CPET and
were followed for 35 months. The parametric Student’s t-test, chi-square
tests, linear regression model and Kaplan-Meier analysis were applied.

RESULTS: We identified 13 (26%) participants with EOV and 37 (74%)
without EOV (N-EOV) during exercise. The EOV group had worse cardiac
function (LVEF: 30 +/- 6% vs. N-EOV 40 +/- 9%, p = 0.007), worse pulmonary
function (FEV1: 1.04 +/- 0.7 L vs. N-EOV 1.88 +/- 0.7 L, p = 0.007), a
higher mortality rate [7 (54%) vs. N-EOV 8 (27%), p = 0.02], higher minute
ventilation/carbon dioxide production (VE/ V CO2) slope (42 +/- 7 vs.
N-EOV 36 +/- 8, p = 0.04), reduced peak ventilation (L/min) (26.2 +/- 16.7
vs. N-EOV 40.3 +/- 16.4, p = 0.01) and peak oxygen uptake (mlO2 kg-1
min-1) (11.0 +/- 4.0 vs. N-EOV 13.5 +/- 3.4 mlkg-1min-1, p = 0.04) when
compared with N-EOV group. We found that EOV group had a higher risk of
mortality during follow-up (long-rank p = 0.001) than patients with N-EOV
group.

CONCLUSION: The presence of EOV is associated with greater severity of
coexisting HFrEF and COPD and a reduced prognosis. Assessment of EOV in
participants with coexisting HFrEF-COPD, as a biomarker for both clinical
status and prognosis may therefore be warranted.

Martin de Miguel I; Hospital Universitario 12 de Octubre, Madrid, Spain;
Jimenez Lopez-Guarch C; Segura de La Cal T; Huertas
Nieto S; Sarnago Cebada F; Velazquez Martin M; Maneiro Melon N; Cruz
Utrilla A; Biscotti Rodil B; Gutierrez-Ortiz E; Arribas Ynsaurriaga F;
Escribano Subias P

Chest. 169(3):769-783, 2026 Mar.

BACKGROUND: Chronic thromboembolic pulmonary disease corresponds to
exercise impairment after a pulmonary embolism due to persistent chronic
thrombi and exercise pulmonary hypertension (PH). Diagnosis requires
exercise right heart catheterization (RHC), whereas data on noninvasive
diagnosis are scarce.

RESEARCH QUESTION: Is there an association between noninvasive parameters
and exercise PH among symptomatic patients with chronic thromboembolism?

STUDY DESIGN AND METHODS: Data come from a prospective cohort of 92
patients with chronic thrombi and absence/only mild resting PH undergoing
cardiopulmonary exercise testing and exercise RHC with concomitant
echocardiography. Clinical, functional, imaging, and hemodynamic data were
documented. Exercise PH was defined as mean pulmonary artery
pressure/cardiac output slope > 3 mm Hg/L/min.

RESULTS: The mean age of the patients was 52.7 +/- 14.3 years, and 62.0%
were male. A total of 37 patients (40.2%) developed exercise PH. Patients
with exercise PH had lower peak oxygen consumption, lower peak exercise
oxygen saturation, and higher ventilatory inefficiency. At rest and peak
exercise, they had higher tricuspid regurgitation peak velocity (TRPV),
lower tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery
systolic pressure (PASP) ratio, invasively higher pulmonary pulse
pressure, and lower pulmonary artery compliance. Peak exercise aortic
saturation, peak oxygen consumption, partial pressure of end-tidal CO2 at
first ventilatory threshold, TRPV, and TAPSE/PASP ratio were independent
predictors of exercise PH. Two weighted risk scores including age, partial
pressure of end-tidal CO2 at first ventilatory threshold, and peak TRPV or
peak TAPSE/PASP identified patients at low vs high risk of exercise PH.

INTERPRETATION: Our results show that symptomatic patients with chronic
thrombi and exercise PH had impaired right ventricular contractile reserve
and augmented afterload assessed by cardiopulmonary exercise testing,
exercise echocardiography, and exercise RHC. Two noninvasive
multiparametric scores aided stratification of low vs high risk of
exercise PH.

Maggio ABR; University Hospitals of Geneva, Geneva, Switzerland,
Perret I; Alramadina N; Perrin A; Barazzone C; Mornand A

Pulmonary Medicine. 2026(1):e5599011, 2026.

BACKGROUND: Post-COVID syndrome (PCS) in adolescents, marked by persistent
symptoms such as dyspnea and fatigue, remains poorly understood,
particularly in those referred for exercise intolerance.

OBJECTIVE: The objective of this study is to describe the clinical
presentation and cardiorespiratory fitness (CRF) of adolescents with PCS
and identify factors distinguishing those with normal versus reduced CRF.

STUDY DESIGN: In this cross-sectional study, 31 adolescents (90% female)
with PCS underwent cardiopulmonary exercise testing (CPET), pulmonary
function tests, and completed validated questionnaires assessing fatigue,
depression, hyperventilation, physical activity, and quality of life
(QoL). Patients were grouped by CRF status and compared.

RESULTS: Symptoms were more prevalent than in general PCS literature,
likely due to referral bias. Moderate depression risk was present in 35%,
and 75% reported QoL impairment comparable with chronic conditions. Nearly
half (48%) had reduced CRF. CRF was not associated with acute infection
severity but correlated with orthostatism, reduced O2 pulse, and increased
static air trapping (p < 0.05). Preinfection physical activity was
positively associated with CRF (p = 0.014), whereas postinfection activity
levels were similar across groups.

CONCLUSION: PCS significantly impacts CRF, QoL, and psychological
well-being in adolescents with exercise intolerance. Reduced CRF appears
multifactorial, involving autonomic dysfunction, pulmonary limitations,
and deconditioning. These findings underscore the need for comprehensive
evaluation and targeted management strategies in this vulnerable
population.

Hayiroglu MI; Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
Cinar T; Cilli Hayiroglu S; Saylik F; Uzun M; Tekkesin AI

Acta Cardiologica. 78(9):1000-1005, 2023 Nov.

BACKGROUND: This investigation aims to assess the influence of a mobile
application and smart devices on cardiopulmonary exercise testing (CPET)
over a one-year period in individuals who have high risk for
cardiovascular disease.

METHODS: This is a post-hoc subgroup analysis of Lifestyle Intervention
Using Mobile Technology in Patients with High Cardiovascular Risk: A
Pragmatic Randomised Clinical Trial (LIGHT). In the intervention plus
standard care standard standard care arms, 138 and 103 patients were
recruited, respectively. The 1-year VO2 measurements were adjusted to the
baseline VO2 measurements as the study’s endpoint. VO2 measurements were
taken for each subject during the randomisation and final CPET
examinations.

RESULTS: The intervention plus standard care improved VO2 measurements by
1.1 (adjusted treatment effect 1.1, 95% confidence interval (CI): 0.8,
1.4, p < 0.001) compared to standard care following 1-year follow-up.

CONCLUSION: At a 1-year follow-up, the smart device and mobile
application technologies increased VO2 measurements in individuals with
high cardiovascular risk compared to conventional treatment alone.
Publication Type

Campbell N; Department of Critical Care. Scottish Liver Transplant Unit, Royal Infirmary of
Edinburgh, Edinburgh, UK.
Beattie C; Gillies MA

Current Opinion in Critical Care. 32(2):179-186, 2026 Apr 01.

PURPOSE OF REVIEW: Survival rates following liver transplantation now
exceed 90% at one year. However, the patient group undergoing liver
transplantation is increasingly complex, requiring continued focus on
improving perioperative care to sustain these survival outcomes. This
review highlights recent advances in the postoperative care of the liver
transplantation patient.

RECENT FINDINGS: Modern care integrates Enhanced Recovery After Surgery
(ERAS) principles, which emphasise early mobilisation and device
minimisation. Risk stratification has become increasingly sophisticated,
with frailty and cardiopulmonary exercise testing providing powerful
prognostic information; emerging machine learning approaches may further
refine personalised risk prediction.Goal-directed haemodynamic management
is advocated, with restrictive fluid strategies and viscoelastic
haemostatic assays to minimise transfusion. Advances in graft optimisation
have expanded the donor pool: normothermic regional perfusion reduces
ischaemic cholangiopathy in donation after cardiac death grafts, while
machine perfusion systems show promise in improving early graft
function.Advanced organ support (extracorporeal membrane oxygenation)
requires careful graft-conscious management. Infection prevention
strategies include tailored prophylaxis approaches. Nutrition and
structured prehabilitation/rehabilitation programmes support recovery,
reduce complications and address persistent functional deficits.

SUMMARY: Collectively, these developments reflect a shift toward
personalised, multidisciplinary postoperative care, aimed at improving
both survival and quality of life for liver transplantation recipients.